Archive for June, 2021

$XPHYF What Is Long COVID and What Do We Know About It?

The majority of individuals who contract the coronavirus suffer from the symptoms of coughing, fever and difficulty breathing before recovering in about two weeks. However, some individuals suffer persistent symptoms, informally referred to as long COVID. Researchers estimate that these individuals make up 10% to 30% of the population.

While researchers have been unable to find a definitive cause as to why some people suffer from long-term symptoms, they have proposed a few theories as well as growing information about the disease.

So, what can we deduce from long COVID?

Working definitions from researchers show that the term “long COVID” describes a situation where individuals experience persistent symptoms after contracting the coronavirus. The most common symptoms observed in sufferers of long COVID are sleep disturbance, muscle aches, brain fog, headaches, heart palpitations, chest pain, shortness of breath and fatigue. However, researchers note that individuals may also experience symptoms such as an inability to interact with and work in society, depression, and loss of taste and smell.

Researchers aren’t sure what causes long COVID but theorize that an individual’s immune system may misfire when they’re infected. This is supported by the improvements observed in the symptoms of patients who suffer from long COVID after they’ve received the coronavirus vaccine. The researchers note that no final conclusions have been made and that it is challenging to determine the proportion of individuals who contract the coronavirus and end up with persistent symptoms.

However, a current study focused on coronavirus immunity is being conducted by the Walter and Eliza Hall Institute. That study has discovered that more than 30% of the participants are still experiencing symptoms of long COVID some 40 weeks after diagnosis. It should be noted that the study isn’t community based and was not developed to measure how common long COVID was in the wider population.

Additionally, data emerging from other sources cites different rates, with another study conducted in the UK finding a 30% rate and a separate study by the WHO noting that the rate is 10%. Researchers note that the proportion of individuals who are affected by the disease may also vary between different countries.

As there are no definitive clinical tests to determine whether an individual has the disease, treating it can be challenging. Clinicians observe that individuals suffering from mild symptoms may not need treatment, but information and validation may be useful. However, those suffering from persistent symptoms should seek clinical care, as it is essential that these severe symptoms get acknowledged so that they can be treated by a multidisciplinary medical team and allow patients to receive valuable support and assistance.

As superior Covid-19 diagnostics are brought to market by companies such as XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a time may come when long Covid is better understood by the medical community.

NOTE TO INVESTORS: The latest news and updates relating to XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) are available in the company’s newsroom at https://ibn.fm/XPHYF

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Tuesday, June 29th, 2021 Uncategorized Comments Off on $XPHYF What Is Long COVID and What Do We Know About It?

$VTGN Reports Fiscal Year 2021 Financial Results and Provides Corporate Update

PALISADE-1 Phase 3 trial underway to evaluate PH94B for rapid-onset acute treatment of anxiety in adults with social anxiety disorder (SAD)

Management to host corporate update conference call and audio webcast today at 2:00 p.m. PT

SOUTH SAN FRANCISCO, Calif., June 29, 2021 — VistaGen Therapeutics , Inc. (NASDAQ: VTGN), a biopharmaceutical company committed to developing and commercializing a new generation of medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system (CNS) disorders, today provided a corporate update and reported financial results for its fiscal year ended March 31, 2021.

“Our fiscal year 2021 was transformative, involving several drug development, financial and regulatory milestones that fortified the foundation for our very strong start this fiscal year. Notably, we achieved an important consensus with the U.S. Food and Drug Administration regarding our PALISADE Phase 3 program for PH94B in social anxiety disorder. Building on that positive meeting, we completed a PH94B collaboration in ex-U.S. markets, strengthened our balance sheet with substantial investment from numerous long-biased, healthcare-focused institutional investors, and advanced several development programs across our CNS pipeline, most notably preparations for PALISADE-1, our U.S. multi-center Phase 3 clinical study of PH94B as a potential rapid-onset, acute treatment of anxiety in adults with social anxiety disorder. If successful, PALISADE-1 is designed to be among the studies necessary to support a potential PH94B New Drug Application to the U.S. Food and Drug Administration in 2023. We recently initiated PALISADE-1, moving us closer to our goal of going beyond the current treatment paradigm for social anxiety disorder, not only displacing antidepressants, benzodiazepines and beta blockers, but also reaching those in need of support who find those therapies to be undesirable or inadequate. We anticipate topline data from PALISADE-1 in mid-2022. Later this year, we expect to launch PALISADE-2, a second U.S. multi-center Phase 3 clinical study of PH94B designed to be substantially similar to PALISADE-1 and equally supportive of our U.S. New Drug Application goal.”

Singh added, “During the current fiscal year, we also expect to prepare for and initiate several exploratory Phase 2A clinical trials of PH94B in additional anxiety disorders, advance preparations necessary to initiate a U.S. multi-center Phase 2B clinical trial of PH10 as a potential rapid-onset, stand-alone treatment for major depressive disorder, and initiate a Phase 1B clinical trial of AV-101 with probenecid, which, if successful, has the potential to support exploratory Phase 2A development of the combination in several CNS disorders.”

“To develop and commercialize game-changing treatments, you need great people. During the past year, we have strengthened our team by adding several key personnel with deep CNS drug development and commercial experience to drive our programs through important late-stage development milestones and appropriately-timed pre-commercial and commercial launch operations. We look forward to initiating several more clinical trials this fiscal year and remain focused on pursuing our mission to improve mental health and well-being for individuals in the U.S. and abroad,” concluded Singh.

Corporate Highlights

  • Reached consensus with U.S. Food and Drug Administration (FDA) on key aspects of the design of Phase 3 clinical trials of PH94B for acute treatment of anxiety in adults with SAD after a positive meeting. The Phase 3 clinical studies of PH94B in the Company’s PALISADE Phase 3 program will substantially mirror the public speaking challenge in the statistically significant Phase 2 study of PH94B, providing significant time and cost-efficiency for the program.
  • Entered into a strategic licensing and collaboration agreement with EverInsight Therapeutics, Inc. (now AffaMed Therapeutics, Inc.) for clinical development and commercialization of PH94B in Greater China, South Korea and Southeast Asia (Territory), pursuant to which VistaGen received a non-dilutive upfront payment of $5 million. VistaGen is eligible to receive additional development and commercial milestone payments of up to $172 million and tiered royalties on sales of PH94B in the Territory, if Phase 3 development efforts there are successful.
  • Reported positive preclinical data differentiating the mechanism of action (MOA) of PH94B and PH10 from risk-ridden benzodiazepines, demonstrating that the MOA of PH94B and PH10 does not involve direct activation of GABA-A receptors, in distinct contrast to the MOA of benzodiazepines, which act as direct positive modulators of GABA-A receptors.
  • Reported positive preclinical data demonstrating the potential of the combination of AV-101 and probenecid to substantially increase the brain concentration of AV-101’s active metabolite, 7-Cl-KYN, a potent and selective full antagonist of the NMDA receptor glycine co-agonist site, thereby reducing, rather than blocking, NMDA receptor signaling.
  • Raised $127.5 million gross proceeds from partnering and corporate finance transactions, including a $100 million underwritten public offering led by Jefferies Group LLC and William Blair & Company involving significant participation from key healthcare-focused institutional investors, such as Acuta Capital, New Enterprise Associates, OrbiMed and Venrock Healthcare Capital Partners.
  • Appointed key senior leadership to execute corporate initiatives through commercialization.

CNS Pipeline Updates

PH94B

PH94B is a synthetic investigational neurosteroid developed from proprietary compounds called pherines. With its novel MOA, PH94B is an odorless nasal spray administered at microgram-level doses to achieve rapid-onset anti-anxiety, or anxiolytic, effects. The novel pharmacological MOA of PH94B is fundamentally differentiated from that of all FDA-approved anti-anxiety drugs, including all antidepressants approved by the FDA for treatment of SAD, as well as all benzodiazepines and beta blockers prescribed on an off-label basis. PH94B engages peripheral chemosensory receptors in nasal passages that trigger a subset of neurons in the main olfactory bulbs (OB) at the base of the brain. The OB neurons then stimulate inhibitory GABAergic neurons in the limbic amygdala, decreasing the activity of the sympathetic nervous system, and facilitating fear extinction activity of the limbic-hypothalamic system, the main fear and anxiety center in the brain, as well as in other parts of the brain. Importantly, PH94B does not require systemic uptake and distribution to produce its rapid-onset anti-anxiety effects.

VistaGen recently initiated its PALISADE Phase 3 program with PALISADE-1, a U.S., multi-center, randomized, double-blind, placebo-controlled Phase 3 clinical study to evaluate the efficacy and safety of PH94B for the acute treatment of anxiety in adults with SAD. The Company expects to initiate PALISADE-2, the second U.S. Phase 3 study in its PALISADE Phase 3 program, in the second half of 2021. If successful, these clinical studies are designed to be among the studies necessary to support a potential U.S. New Drug Application (NDA) to the FDA. PH94B has been granted Fast Track designation status by the FDA for development as an acute treatment of anxiety in adults with SAD.

In addition to SAD, the Company is also preparing for exploratory Phase 2A clinical studies of PH94B in adults experiencing other anxiety disorders, including adjustment disorder with anxiety, postpartum anxiety, post-traumatic stress disorder, and pre-procedural anxiety.

PH10

PH10 is a synthetic investigational neurosteroid, which also was developed from proprietary compounds called pherines. Its novel, rapid-onset MOA is fundamentally differentiated from the MOA of all current treatments for major depressive disorder (MDD) and other depression disorders. PH10 is self-administered at microgram-level doses as an odorless nasal spray. PH10 activates nasal chemosensory cells in the nasal passages, connected to neural circuits in the brain that produce antidepressant effects. Specifically, PH10 engages peripheral chemosensory receptors in the nasal passages that trigger a subset of neurons in the main OB that stimulate neurons in the limbic amygdala. This is turn increases activity of the limbic-hypothalamic sympathetic nervous system and increases the release of catecholamines. Importantly, unlike all currently approved oral antidepressants, PH10 does not require systemic uptake and distribution to produce rapid-onset of antidepressant effects. In all clinical studies to date, PH10 has not caused psychological side effects (such as dissociation and hallucinations) or safety concerns that may be associated with rapid-onset ketamine-based therapy, including intravenous ketamine or intranasal ketamine.

Exploratory Phase 2A clinical development of PH10 for MDD has been completed. VistaGen is now preparing for Phase 2B clinical development of PH10. The Company expects to initiate a U.S. multi-center, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of PH10 as a potential stand-alone treatment for MDD in mid-2022. PH10 also has potential as a novel treatment for treatment-resistant depression, postpartum depression and suicidal ideation.

AV-101

AV-101 is an oral prodrug of 7-chloro-kynurenic acid (7-Cl-KYNA) and targets the N-methyl-D-aspartate receptor (NMDAR), an ionotropic glutamate receptor in the brain. Abnormal NMDAR function is associated with numerous CNS diseases and disorders. AV-101 is a potent and selective full antagonist of the glycine co-agonist site of the NMDAR that inhibits the function of the NMDAR. However, unlike ketamine and many other NMDAR antagonists, 7-Cl-KYNA is not an ion channel blocker. At doses administered in all studies to date, AV-101 has been observed to be orally bioavailable, well tolerated and has not exhibited dissociative or hallucinogenic psychological side effects or safety concerns. In light of these findings and data from preclinical studies, the Company believes that AV-101, in combination with FDA-approved probenecid, has potential to become a new oral treatment alternative for MDD and certain neurological indications involving the NMDAR.

VistaGen is currently preparing for a Phase 1B clinical study to evaluate AV-101 in combination with probenecid. The Company expects to initiate the study in the second half of 2021. The FDA has granted Fast Track designation for development of AV-101 as a potential adjunctive treatment for MDD and as a non-opioid treatment for neuropathic pain. AV-101 also has the potential to be developed as a treatment for levodopa-induced dyskinesia, suicidal ideation, and epilepsy.

Key senior leadership additions

VistaGen strengthened its leadership by adding key personnel with extensive CNS drug development and commercial experience to drive its clinical and commercial programs through important late-stage clinical development milestones and potential commercial launch and beyond. The Company recently added key team members in multiple areas such as clinical operations, research and development, CMC, regulatory affairs and commercial operations. Notably, the addition of Ann Cunningham as the Company’s Chief Commercial Officer has advanced pre-commercial planning for PH94B in SAD, as well as for a broad range of other anxiety and depression markets. The Company also added pharmaceutical industry veteran Dr. Joanne Curley to its Board of Directors. Dr. Curley has deep experience in pharmaceutical product development, operations, and commercialization.

Fiscal Year 2021 Financial Results

Revenue: The Company recognized $1.1 million in sublicense revenue from its $5 million non-dilutive upfront payment pursuant to its PH94B development and commercialization agreement with EverInsight Therapeutics (now AffaMed Therapeutics) during the year ended March 31, 2021, compared to none in the year ended March 31, 2020.

Research and development (R&D) expense: Research and development expense decreased from $13.4 million to $12.5 million for the years ended March 31, 2020 and 2021, respectively. The decrease is primarily due to the completion of a Phase 2 clinical study of AV-101 in MDD in Fiscal 2020, offset by increased development expenses for PH94B and PH10 in Fiscal 2021.

General and administrative (G&A) expense: General and administrative expense decreased to approximately $6.5 million from approximately $7.4 million for the years ended March 31, 2021 and 2020, respectively. Cash compensation expense for the year ended March 31, 2021 increased by approximately $0.7 million, including the impact of new employees, and was offset by a decrease of approximately $1.0 million in noncash stock-based compensation for the year ended March 31, 2021 compared to those expenses in the year ended March 31, 2020. Further, in the year ended March 31, 2020, the Company modified certain outstanding warrants and recognized non-cash warrant modification expense of approximately $0.8 million.

Net loss: Net loss for the fiscal years ended March 31, 2021 and 2020 was approximately $17.9 million and $20.8 million, respectively.

Cash Position: At March 31, 2021, the Company had cash and cash equivalents of approximately $103.1 million.

As of June 29, 2021, the Company had 191,382,350 shares of common stock outstanding.

Conference Call

VistaGen will host a conference call and live audio webcast this afternoon at 2:00 p.m. Pacific Time to provide a corporate update and discuss its financial results for its fiscal year ended March 31, 2021.

U.S. Dial-in (Toll Free): 1-877-407-9716
International Dial-in Number (Toll): 1-201-493-6779
Conference ID: 13720908
Webcast Link: http://public.viavid.com/index.php?id=145419

A telephone playback of the conference call will be available after approximately 5:00 p.m. Pacific Time on June 29, 2020. To listen to the replay, call toll free 1-844-512-2921 within the United States or 1-412-317-6671 when calling internationally (toll). Please use the replay PIN number 13720908.

About VistaGen
VistaGen Therapeutics is a biopharmaceutical company committed to developing and commercializing innovative medicines with the potential to go beyond the current standard of care for anxiety, depression, and other CNS disorders. Each of VistaGen’s drug candidates has a differentiated potential mechanism of action, has been well-tolerated in all clinical studies to date and has therapeutic potential in multiple CNS indications. For more information, please visit www.VistaGen.com and connect with VistaGen on Twitter LinkedIn , and Facebook .

Forward Looking Statements

This press release contains certain forward-looking statements within the meaning of the federal securities laws. These forward-looking statements involve known and unknown risks that are difficult to predict and include all matters that are not historical facts. In some cases, you can identify forward-looking statements by the use of words such as “may,” “could,” “expect,” “project,” “outlook,” “strategy,” “intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “strive,” “goal,” “continue,” “likely,” “will,” “would” and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by us and our management, are inherently uncertain. Our actual results or developments may differ materially from those projected or implied in these forward-looking statements. Factors that may cause such a difference include, without limitation, risks and uncertainties relating to delays in launching and/or conducting our planned clinical trials, including delays due to the impact of the COVID-19 pandemic; fluctuating costs of materials and other resources required to conduct our planned clinical and non-clinical trials; market conditions; the impact of general economic, industry or political conditions in the United States or internationally; adverse healthcare reforms and changes of laws and regulations; manufacturing and marketing risks, which may include, but are not limited to, unavailability of or delays in delivery of raw materials for manufacture of our CNS drug candidates and difficulty in initiating or conducting clinical trials; inadequate and/or untimely supply of one or more of our CNS drug candidates to meet demand; entry of competitive products; and other technical and unexpected hurdles in the development, manufacture and commercialization of our CNS drug candidates; and the risks more fully discussed in the section entitled “Risk Factors” in our most recent Annual Report on Form 10-K for the fiscal year ended March 31, 2021, filed earlier today, as well as discussions of potential risks, uncertainties, and other important factors in our other filings with the U.S. Securities and Exchange Commission (SEC). Our SEC filings are available on the SEC’s website at www.sec.gov. You should not place undue reliance on these forward-looking statements, which apply only as of the date of this press release and should not be relied upon as representing our views as of any subsequent date. We explicitly disclaim any obligation to update any forward-looking statements, other than as may be required by law. If we do update one or more forward-looking statements, no inference should be made that we will make additional updates with respect to those or other forward-looking statements.

VistaGen Company Contacts
Mark McPartland and Mark Flather
VistaGen Therapeutics
Phone: (650) 577-3606; (650) 577-3617
Email: IR@vistagen.com

VISTAGEN THERAPEUTICS, INC.
CONSOLIDATED BALANCE SHEETS
(Amounts in dollars, except share amounts)
March 31, March 31,
2021 2020
ASSETS
Current assets:
Cash and cash equivalents $ 103,108,300 $ 1,355,100
Receivable from collaboration partner 40,600
Prepaid expenses and other current assets 835,100 225,100
Deferred contract acquisition costs – current portion 133,500
Total current assets 104,117,500 1,580,200
Property and equipment, net 367,400 209,600
Right of use asset – operating lease 3,219,600 3,579,600
Deferred offering costs 294,900 355,100
Deferred contract acquisition costs – non-current portion 234,100
Security deposits and other assets 47,800 47,800
Total assets $ 108,281,300 $ 5,772,300
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
Current liabilities:
Accounts payable $ 838,300 $ 1,836,600
Accrued expenses 1,562,700 561,500
Current notes payable 56,500
Deferred revenue – current portion 1,420,200
Operating lease obligation – current portion 364,800 313,400
Financing lease obligation – current portion 3,000 3,300
Total current liabilities 4,189,000 2,771,300
Non-current liabilities:
Accrued dividends on Series B Preferred Stock 6,272,700 5,011,800
Deferred revenue – non-current portion 2,490,300
Operating lease obligation – non-current portion 3,350,800 3,715,600
Financing lease obligation – non-current portion 3,000
Total non-current liabilities 12,113,800 8,730,400
Total liabilities 16,302,800 11,501,700
Commitments and contingencies
Stockholders’ equity (deficit):
Preferred stock, $0.001 par value; 10,000,000 shares authorized at March 31, 2021 and 2020:
Series A Preferred, 500,000 shares authorized, issued and outstanding at March 31, 2021 and 2020 500 500
Series B Preferred; 4,000,000 shares authorized at March 31, 2021 and 2020; 1,131,669 shares
and 1,160,240 shares issued and outstanding at March 31, 2021 and 2020, respectively 1,100 1,200
Series C Preferred; 3,000,000 shares authorized at March 31, 2021 and 2020; 2,318,012 shares
issued and outstanding at March 31, 2021 and 2020 2,300 2,300
Series D Preferred; 2,000,000 shares and no shares authorized at March 31, 2021 and 2020, respectively;
402,149 shares and no shares issued and outstanding at March 31, 2021 and March 31, 2020, respectively 400
Common stock, $0.001 par value; 325,000,000 shares and 175,000,000 shares authorized at March 31, 2021 and 2020,
respectively; 180,751,234 and 49,348,707 shares issued at March 31, 2021 and 2020, respectively 180,800 49,300
Additional paid-in capital 315,603,100 200,092,800
Treasury stock, at cost, 135,665 shares of common stock held at March 31, 2021 and 2020 (3,968,100 ) (3,968,100 )
Accumulated deficit (219,841,600 ) (201,907,400 )
Total stockholders’ equity (deficit) 91,978,500 (5,729,400 )
Total liabilities and stockholders’ equity (deficit) $ 108,281,300 $ 5,772,300
VISTAGEN THERAPEUTICS
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(Amounts in Dollars, except share amounts)
Fiscal Years Ended March 31,
2021 2020
Sublicense revenue $ 1,089,500 $
Total revenues 1,089,500
Operating expenses:
Research and development 12,476,400 13,374,200
General and administrative 6,546,900 7,427,300
Total operating expenses 19,023,300 20,801,500
Loss from operations (17,933,800 ) (20,801,500 )
Other income and expenses, net:
Interest income, net 1,600 30,100
Other income 600
Loss before income taxes (17,931,600 ) (20,771,400 )
Income taxes (2,600 ) (2,600 )
Net loss and comprehensive loss $ (17,934,200 ) $ (20,774,000 )
Accrued dividends on Series B Preferred stock (1,385,600 ) (1,263,600 )
Beneficial conversion feature on Series D
Preferred stock (23,000,000 )
Net loss attributable to common stockholders $ (42,319,800 ) $ (22,037,600 )
Basic and diluted net loss attributable to common
stockholders per common share $ (0.49 ) $ (0.50 )
Weighted average shares used in computing
basic and diluted net loss attributable to common
stockholders per common share 86,133,644 43,869,523


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

Tuesday, June 29th, 2021 Uncategorized Comments Off on $VTGN Reports Fiscal Year 2021 Financial Results and Provides Corporate Update

$WTER Leading the Independent Pack, Poised in Market Projected to Hit $1B

The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER) achieved $41.1 million in revenue for fiscal year 2020, representing a 28% year-over-year increase as reflected in its most recent financial report. Now the largest independent alkaline water company in the nation, the company’s accomplishment to lead the pack is impressive and positions it well as the market is projected to reach $1 billion in 2022 (https://cnw.fm/oXjm6). “WTER has shown consistent growth since the release of its flagship product: Alkaline88(R). Alkaline88 ionized water contains only two ingredients — water and Pink Himalayan rock salt — and has built a reputation for superior hydration with a perfect 8.8 pH balance. The brand was formulated to offer a smooth taste that encourages consumers to drink more and fully hydrate, key factors in maintaining health and wellness,” reads a recent article. “Alkaline88 is now available in more than 75,000 retail stores nationwide, and in addition to being number one in the indie alkaline water space, the brand has captured a prestigious spot as one of the top-10 largest enhanced water brands in the country as well. As per Nielsen data, the brand is the only top-10, nonflavored, value-added water brand that has consistently grown double digits in both units and dollar volume every four-week period since the end of 2019. In addition, research indicates that Alkaline88 has the greatest brand loyalty among alkaline water drinkers.”

To view the full article, visit: https://cnw.fm/SJO2X

About The Alkaline Water Company Inc.

Founded in 2012, The Alkaline Water Company is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88(R), is a leading premier alkaline water brand available in bulk and single-serve sizes along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88 delivers perfect 8.8 pH-balanced alkaline drinking water with trace minerals and electrolytes and boasts its trademarked label: Clean Beverage. Quickly being recognized as a growing lifestyle brand, Alkaline88 launched A88 Infused(TM) in 2019 to meet consumer demand for flavor-infused products. A88 Infused flavored water is available in six unique, all-natural flavors with new flavors coming soon. Additionally, in 2020, the company launched A88 Infused Beverage Division Inc., which includes the company’s CBD water and flavor-infused water. For the company’s topical and ingestible offerings, A88 Infused Products Inc. includes the company’s lab-tested, hemp-extract salves, balms, lotions, essential oils, bath salts, powder packs, oil tinctures, capsules, and gummies. To learn more about the company, visit www.TheAlkalineWaterCo.com.

NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://cnw.fm/WTER

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Tuesday, June 29th, 2021 Uncategorized Comments Off on $WTER Leading the Independent Pack, Poised in Market Projected to Hit $1B

$RWBYF Launches High Times Branded Vapes Throughout Michigan

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, today announced the successful launch of High Times branded vapes into the Michigan market. Building on RWB’s partnerships and the successful launch of High Times branded packaged flower and pre-rolls earlier in the year, the company is pleased to introduce the High Times branded vapes, offered as premium live resin and distillate cartridges. The High Times branded vapes and previously launched products are available at 22 of Michigan’s finest dispensaries, while the High Times branded product portfolio will be made available to a significant number of the 250+ dispensaries in the state in the second half of 2021. “As I’ve stated before, we look forward to bringing exceptional quality, price and experience through our house of brands and product lines to loyal consumers in Michigan,” said Brad Rogers, RWB’s chairman and CEO. “We have been able to utilize partnerships in Michigan to establish branded product sales and are currently in the final steps of establishing our own operations in Michigan to allow us to utilize all that we have learned and leverage the investments we have made to accelerate that growth.”

To view the full press release, visit https://ibn.fm/rlRup

About Red White & Bloom Brands Inc.

The company is positioning itself to be one of the top three multistate cannabis operators active in the U.S. legal cannabis and hemp sector. RWB is predominantly focusing its investments on the major U.S. markets, including Michigan, Illinois, Florida, California, Oklahoma, Arizona, and Massachusetts with respect to cannabis, and the U.S. and internationally for hemp-based CBD products. For more information about the company, visit www.RedWhiteBloom.com.

NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at http://ibn.fm/RWBYF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Tuesday, June 29th, 2021 Uncategorized Comments Off on $RWBYF Launches High Times Branded Vapes Throughout Michigan

$NEXCF EdTechX Enabling Valuable Digital Learning Experiences

Nextech (CSE: NTAR) (NEO: NTAR) (OTCQB: NEXCF) (FSE: N29), a provider of virtual and augmented reality (“AR”) experience technologies and services for e-commerce, education, advertising, conferences, and events, recently launched EdTechX. EdTechX is a global higher education solution built on Microsoft Azure and available on Nextech’s LiveX Digital Experience Platform (“DXP”). According to a recent article, EdTechX enables education institutions “to move with the times by transforming traditional learning and event formats into valuable digital experiences.” The solution solves problems previously linked to virtual learning, including the inability to reproduce the sort of instructor-student engagement present in the class environment and the shortcomings of software for conference calls, which cannot provide a personalized experience nor handle large classes. The article quoted Nancy Teodoro, education partner lead at Microsoft (NASDAQ: MSFT) Canada, as saying, “Nextech AR Solutions is helping education institutions digitally transform the way educators teach and the way students learn by enabling remote experiential learning through EdTechX.”

To view the full article, visit https://ibn.fm/fx4Yo

About Nextech AR Solutions Corp.

Nextech develops and operates augmented reality (“AR”) platforms that transport three-dimensional (“3D”) product visualizations, human holograms and 360° portals to its audiences, altering e-commerce, digital advertising, hybrid virtual events (events held in a digital format blended with in-person attendance) and learning and training experiences. Nextech focuses on developing AR solutions; however, most of the company’s revenues are derived from three e-commerce platforms, VacuumCleanerMarket.com (“VCM”), InfinitePetLife.com (“IPL”) and TruLyfeSupplements.com (“TruLyfe”), as well as VCM and product sales of residential vacuums, supplies, and parts, and small home appliances sold on Amazon. For more information about the company, visit www.NextechAR.com.

NOTE TO INVESTORS: The latest news and updates relating to NEXCF are available in the company’s newsroom at https://ibn.fm/NEXCF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Tuesday, June 29th, 2021 Uncategorized Comments Off on $NEXCF EdTechX Enabling Valuable Digital Learning Experiences

$KAVL Issues Statement on Continued Commitment to High Compliance Standards in ENDS Industry

Kaival Brands (OTCQB: KAVL) is the exclusive global distributor of products manufactured by Bidi Vapor LLC, including the BIDI(R) Stick disposable electronic nicotine delivery system (“ENDS”), intended exclusively for adults 21 and over. Kaival Brands today issued a statement prioritizing its compliance with the Tobacco Control Act and the PACT Act. “First and foremost, our chief concern and priority is continuing to prevent youth access to Bidi Vapor products,” said Kaival Brands CEO Niraj “Raj” Patel in the press release. “We are parents and run our company with youth prevention as a priority. These increased precautions add levels of protection that not only help prevent our products from reaching minors, but also protect adult consumers from potentially dangerous and hazardous counterfeit products. As partners, Bidi Vapor and Kaival Brands spare no expense to go above and beyond the stringent regulatory requirements. However, with the current state of limited enforcement, it does make being one of the few companies playing by the rules challenging. Nonetheless, we will continue to hold ourselves to our own high compliance standards and will continue to be a leader for the ENDS industry, because it is the right thing to do.”

To view the full press release, visit https://ibn.fm/WaY5S

About Kaival Brands Innovations Group Inc.

Based in Grant, Florida, Kaival Brands is a company focused on growing and incubating innovative and profitable products into mature and dominant brands in their respective markets. The company’s vision is to develop internally, acquire, own, or exclusively distribute these innovative products and grow each into dominant market-share brands with superior quality and recognizable innovation. Kaival Brands is the exclusive global distributor of all products manufactured by Bidi Vapor LLC. For more information about the company, visit www.KaivalBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to KAVL are available in the company’s newsroom at http://ibn.fm/KAVL

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Tuesday, June 29th, 2021 Uncategorized Comments Off on $KAVL Issues Statement on Continued Commitment to High Compliance Standards in ENDS Industry

$IFBD Digitally Transforming Companies in the Retail Industry

  • Infobird is committed to digitally transforming businesses and whole industries by offering robust customer engagement solutions that embody the crucial aspects of digital transformation
  • These aspects, enumerated by Deloitte China, include: digital, analytics, cloud, cybersecurity, and regulatory compliance
  • Two retail companies have selected IFBD’s solutions in less than a month
  • The collaboration with Zu Li Jian has set up a new path for the digital transformation of retail companies

Evolving customer expectations and business needs have fueled a digital transformation in China, marked by the integration of cloud computing and artificial intelligence (“AI”) into companies’ operations.

“To survive in this new world, businesses must learn to observe, think, and operate differently,” reads Deloitte China’s webpage about digital transformation (https://ibn.fm/nPTXa). “Digital transformation, the cross-disciplinary power comprising digital, analytics, cloud, cybersecurity, and regulatory compliance, is about embracing digital disruption and unlocking exponential value.”

Interestingly, Infobird Software (NASDAQ: IFBD), a Software-as-a-Service (SaaS) company offering AI-enabled end-to-end customer engagement solutions in China, has packaged the aspects of digital transformation mentioned above, i.e., cloud computing, analytics, cybersecurity, and digital, into its robust proprietary solutions and is using them to help companies around China adapt to the changing times and transform digitally.

IFBD’s customer engagement solutions, which integrate the needs of both the customers and the businesses into a single platform, stimulate companies’ market performance and growth and enable them to improve their infrastructure. The platform uses big data and AI to analyze data from multiple channels and subsequently create portraits representing each user, plus their expectations and needs.

The platform’s capabilities enable companies to understand their customers more comprehensively and accurately, creating a foundation for precision marketing in e-commerce and physical stores. It is no wonder that IFBD is increasingly witnessing success within the retail industry.

A company that leveraged its experience in the finance industry to enter other industries and, as a result, grow its standardized SaaS platform, Infobird has already worked with a leading Chinese multinational technology company specializing in e-commerce and retail. Notably, IFBD appears to be experiencing even more success within this sector.

Just recently, Zu Li Jian, the leading shoe company for the elderly in China, selected IFBD’s solutions (https://ibn.fm/WMzM8) less than a month after SaSa Cosmetics (China) Co. Ltd. (https://ibn.fm/rKqzN) entered into a similar cooperative agreement with IFBD. Per both agreements, IFBD’s solutions are intended to digitally improve and optimize the retail companies’ marketing, management, and customer service.

The partnership between IFBD and Zu Li Jian, in particular, has set up a new path for the digital transformation of retail companies. This aligns with IFBD’s commitment to continually contribute to the development of more industries and companies. Further, the cooperation promotes the deployment of AI-based SaaS within the retail sector.

Infobird, which is keen on capturing the Chinese SaaS market share, is increasingly making strides towards attaining this target, all while digitally transforming companies within the retail industry, as well as other industries.

For more information, visit the company’s website at www.Infobird.com/en/index.html.

NOTE TO INVESTORS: The latest news and updates relating to IFBD are available in the company’s newsroom at https://ibn.fm/IFBD

About ChineseWire

ChineseWire (CW) is a specialized communications platform focused on promising China-based companies that are listed in North America. As one of 40+ brands within the InvestorBrandNetwork (“IBN”), CW provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution to IBN’s millions of social media followers; and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, CW is uniquely positioned to best serve private and public Chinese companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CW brings its clients unparalleled visibility, recognition and brand awareness. CW is where news, content and information converge.

For more information, please visit https://www.ChineseWire.com

Please see full terms of use and disclaimers on the ChineseWire website applicable to all content provided by CW, wherever published or re-published: http://IBN.fm/Disclaimer

ChineseWire (CW)
Los Angeles, California
www.ChineseWire.com
310.299.1717 Office
Editor@ChineseWire.com

ChineseWire is part of the InvestorBrandNetwork.

Tuesday, June 29th, 2021 Uncategorized Comments Off on $IFBD Digitally Transforming Companies in the Retail Industry

$IDEX US to Enlist Allies in the Quest for Battery Metals

Unlike the original automotive sector that grew organically over a century into what it is today, the electric vehicle (“EV”) market is expected to hit the ground running and achieve mass-market penetration in only a few decades. Electric vehicles run on rechargeable lithium-ion battery packs rather than internal combustion engines, and produce zero carbon emissions. However, their batteries are made using rare metals such as lithium, and presently, the United States barely has a supply chain that can provide these metals, with American EV makers and established automakers sourcing the metals from foreign supply chains.

China, which is America’s largest competitor on the global stage, is one of the largest processors of EV metals in the world, a that fact doesn’t sit well with the White House. According to a statement released by the White House in early June, the U.S. must reduce and ultimately cut its reliance on Chinese supply chains by working with its allies to secure EV battery materials. Additionally, the country should process these raw materials domestically to ensure the process does not have environmental impacts that could potentially cancel out any progress made by switching to alternative fuel vehicles.

To achieve this, the government will have to provide funding to help expand international investments and beef up supply chains for EV battery materials with allied countries. These funds, which will be provided via the U.S. Department Finance Corporation, will also be used to beef up the supply of these rare metals by recycling EV batteries that have reached the end of their lives. Such batteries pose a major environmental concern as they contain hazardous materials that cannot be successfully recycled using current recycling methods.

Refining battery recycling techniques would allow these metals to be fed back into the supply chain. On top of that, it would keep them from ending up in landfills where they would pollute the environment for years. A 250-page document from the White House recommends securing minerals from allies such as Canada, Finland, Australia and Chile; the last two countries contain the largest lithium reserves in the world. The Biden administration will also launch a group of experts to study and determine how and where EV battery metals, as well as other relevant technologies, can be produced and processed in the country.

Concerning the environmental concerns of mining these metals, the Department of the Interior coupled with other agencies will identify gaps in mining laws to ensure local production will not harm the environment or adjacent communities. Through its Advanced Technology Vehicles Manufacturing Loan Program, the Energy Department will provide $17 billion to help fund those efforts.

As the federal government works to make battery materials locally available, private entities such as Ideanomics Inc. (NASDAQ: IDEX) are bringing innovative products on the market, including wireless charging, which will encourage more people to acquire their first electric vehicle.

NOTE TO INVESTORS: The latest news and updates relating to Ideanomics Inc. (NASDAQ: IDEX) are available in the company’s newsroom at https://ibn.fm/IDEX

About Green Car Stocks

Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge.

To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

Green Car Stocks
San Francisco, California
www.GreenCarStocks.com
415.949.5050 Office
Editor@GreenCarStocks.com

Green Car Stocks is part of the InvestorBrandNetwork.

Tuesday, June 29th, 2021 Uncategorized Comments Off on $IDEX US to Enlist Allies in the Quest for Battery Metals

$CBDHF Positioned for Success in 2021 and Beyond

HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO), a leader in the health and wellness cannabidiol (“CBD”) industry, is keen on expanding its international distribution channels, demonstrating its compliance with regulatory standards for hemp-derived products worldwide, and seeking to expand access points for CBD. The company’s HempFusion USA, through Probulin Probiotics LLC, sells its products in about 4,000 retail locations in all 50 U.S. States. “Probulin’s network for probiotics sales has proved useful for helping the company gain an entry point in marketplaces hesitant to consider CBD,” reads a recent article. In March, the company announced Probulin’s entry into the Asian market through Tmall Global and, in April, announced its products had received Tmall’s conditional approval. HempFusion also sells its Probulin products in Mexico, South Korea, the United Arab Emirates, and Ireland with expectations of entering India and the United Kingdom. According to an April operational update by the company, “COVID and continued lack of clarity from the FDA related to official regulatory guidance for CBD used in dietary supplements, foods and beverages has made 2020 a challenging year. However, these challenges have led to strategic changes, establishing the foundation for HempFusion to succeed in 2021 and beyond.”

To view the full article, visit: https://cnw.fm/7MLWW

About HempFusion Wellness Inc.

HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research, and HF Labs, to approximately 4,000 retailers across all 50 US states and select international locations. Built on a foundation of regulatory compliance and human safety, HempFusion’s diverse product portfolio comprises 46 SKUs, including tinctures, proprietary FDA Drug-listed over-the-counter (“OTC”) topicals, doctor/practitioner lines, and more. With a strong focus on R&D, HempFusion has an additional 30 products under development. HempFusion is a board member of the U.S. Hemp Roundtable, and HempFusion’s wholly-owned subsidiary, Probulin Probiotics, is one of the fastest-growing probiotics companies in the United States, according to SPINs reported data. HempFusion’s CBD products are based on a proprietary Whole Food Hemp Complex(TM) and are available in-store or by visiting HempFusion online at www.Hempfusion.com or www.Probulin.com.

NOTE TO INVESTORS: The latest news and updates relating to CBDHF are available in the company’s newsroom at http://cnw.fm/CBDHF

About HempWireNews

HempWireNews (HWN) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HWN is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWireNews (HWN) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWireNews.com

Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HWN, wherever published or re-published: https://www.HempWireNews.com/Disclaimer

Do you have a questions or are you interested in working with HWN? Ask our Editor

HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net

HempWireNews is part of the InvestorBrandNetwork.

Tuesday, June 29th, 2021 Uncategorized Comments Off on $CBDHF Positioned for Success in 2021 and Beyond

$UUUU Making Strides to Restore Critical US Rare Earth Supply Chains

Energy Fuels (NYSE American: UUUU) (TSX: EFR) continues to focus on its efforts to produce commercial rare earth elements (“REEs”) as well as on uranium production as the U.S. government looks to support moves to limit dependence on other countries for the mining and production of various metals. “Without a doubt, Energy Fuels is making major strides toward restoring critical U.S. rare earth supply chains while also maintaining our position as the leading U.S. uranium producer,” said UUUU’s president and CEO Mark S. Chalmers in a recent update. “On rare earths, our efforts over the past several months culminated in the announcement on March 1 that Energy Fuels and Neo Performance Materials were creating a new, U.S.-European rare earth supply chain. In early March, we began to receive shipments of rare-earth-rich natural monazite sands from Chemours’ Georgia heavy mineral sand operations. In late-March, we began to ramp-up production of an intermediate rare earth product at our White Mesa Mill in Utah using monazite from Chemours. This is expected to be a high-value product ready to be separated and refined into value-added rare earth products at Neo’s plant in Europe. At this time, no other U.S. company is producing a product this far down the rare earth value chain.”

To view the full article, visit https://ibn.fm/rwKyG

About Energy Fuels Inc.

Energy Fuels is a leading U.S.-based uranium mining company, supplying U3O8 to major nuclear utilities. The company also produces vanadium from certain of its projects, as market conditions warrant, and is in the process of ramping up to expected commercial production of REE carbonate in 2021. Its corporate offices are in Lakewood, Colorado, near Denver, and all of its assets and employees are in the United States. Energy Fuels holds three of America’s key uranium production centers: the White Mesa Mill in Utah, the Nichols Ranch in-situ recovery (“ISR”) Project in Wyoming and the Alta Mesa ISR Project in Texas. The White Mesa Mill is the only conventional uranium mill operating in the U.S. today, has a licensed capacity of over 8 million pounds of U3O8 per year and has the ability to produce vanadium when market conditions warrant, as well as REE carbonate and uranium from monazite. The Nichols Ranch ISR Project is currently on standby and has a licensed capacity of 2 million pounds of U3O8 per year. The Alta Mesa ISR Project is also currently on standby. In addition to the above production facilities, Energy Fuels also has one of the largest NI 43-101 compliant uranium resource portfolios in the U.S. and several uranium and uranium/vanadium mining projects on standby and in various stages of permitting and development. The primary trading market for Energy Fuels’ common shares is the NYSE American under the trading symbol “UUUU,” and the company’s common shares are also listed on the Toronto Stock Exchange under the trading symbol “EFR.” For more information, visit the company’s website at www.EnergyFuels.com.

NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU

About MiningNewsWire

MiningNewsWire (MNW) is a specialized communications platform focused on developments and opportunities in the global resources sector. The company provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, MNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MNW brings its clients unparalleled visibility, recognition and brand awareness. MNW is where news, content and information converge.

To receive SMS text alerts from MiningNewsWire, text “BigHole” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, California
www.MiningNewsWire.com
310.299.1717 Office
Editor@MiningNewsWire.com

MiningNewsWire is part of the InvestorBrandNetwork.

Tuesday, June 29th, 2021 Uncategorized Comments Off on $UUUU Making Strides to Restore Critical US Rare Earth Supply Chains

$CNSP Receives FDA Fast Track Status for Berubicin Study

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, announced that the U.S. Food and Drug Administration granted Fast Track Designation for Berubicin, the company’s lead investigational drug. The status was received for the company’s evaluation of Berubicin for the treatment of patients with recurrent glioblastoma multiforme (“GBM”). An anthracycline, Berubicin falls in a class of anticancer agents that are among the most powerful chemotherapy drugs, proven to be effective against more types of cancer than any other category of chemotherapeutic agents. Fast Track Designation provides opportunities to expedite the development and review process for drugs intended to treat serious or life-threatening conditions when those drugs show potential to address unmet medical need. CNS has already begun patient enrollment in its upcoming study of Berubicin for the treatment of recurrent glioblastoma multiforme. “Receiving Fast Track Designation from the U.S. FDA is a huge achievement in our advancement of Berubicin for the treatment of glioblastoma, the most aggressive, deadly and treatment-resistant type of cancer that forms in the brain,” said CNS Pharmaceuticals CEO John Climaco in the press release. “If there were ever a disease where the unmet clinical need demands action, it is GBM. Patients have almost no meaningful options, and thousands lose their fight against this terrible cancer every year. With this designation, we now have an accelerated pathway to approval for Berubicin and a clear opportunity to more expediently bring this potentially impactful investigational therapy to individuals battling this challenging disease.”

To view the full press release, visit https://ibn.fm/m5vPL

About CNS Pharmaceuticals Inc.

CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system. The company’s lead drug candidate, Berubicin, is a novel anthracycline and the first anthracycline to appear to cross the blood-brain barrier. Berubicin is currently in development for the treatment of a number of serious brain and CNS oncology indications including glioblastoma multiforme, an aggressive and incurable form of brain cancer.

Additionally, CNS Pharmaceuticals is advancing the development of its WP1244 drug technology, which utilizes anthracycline and distamycin-based scaffolds to create small molecule agents and is believed to be 500 times more potent than daunorubicin in inhibiting tumor cell proliferation. Preclinical studies of WP1244 demonstrated high uptake in the brain with antitumor activity. CNS Pharmaceuticals is evaluating the use of WP1244 in the treatment of brain, pancreatic and ovarian cancers as well as lymphomas. For more information about the company, please visit www.CNSPharma.com

NOTE TO INVESTORS: The latest news and updates relating to CNSP are available in the company’s newsroom at http://ibn.fm/CNSP

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Tuesday, June 29th, 2021 Uncategorized Comments Off on $CNSP Receives FDA Fast Track Status for Berubicin Study

$XPHYF 420 with CNW – California Earmarks $100M to Support Licensed Cannabis Firms During Pandemic

For many states with legal cannabis markets, one of the objectives of legalizing the controversial drug was to cripple the illicit cannabis market by taking away its clientele. While that sounds like a great idea in theory, most of these states have been unable to do any real damage to the illegal market so far. Not only do black market sellers tend to price their cannabis cheaply, but they don’t have to jump through a wide variety of hoops to start selling, and this ensures the black market has an unending supply of affordable cannabis.

California, for instance, legalized marijuana back in 2016, but a mere four years later, the state’s illicit cannabis market has more than three times the number of registered cannabis sellers. Consequently, the state has earmarked $100 million towards supporting its struggling cannabis industry amid the coronavirus and subsequent financial crisis. State Governor Gavin Newsom proposed a measure that would see these funds used to help businesses in the cannabis space turn their provisional licenses into permanent licenses, and it was recently approved by the legislature.

According to Newsom’s office, around 82% of licensed businesses hold provisional licenses, with most cannabis businesses being unable to convert those licenses to permanent ones due to the high costs involved. The state requires permanent license holders to run their businesses in a way that has minimal to zero negative environmental impact, and this usually leads to higher annual operational costs. As many of the registered operators are equity applicants, small businesses and legacy operators, says Newsom’s senior cannabis advisor Nicole Elliot, these costs are often more than they can handle, preventing them from obtaining permanent licenses.

This one-time $100 million grant will be used to help cities in the state employ professionals and staff to assist with the process of turning provisional licenses into permanent ones as well as to aid in business operations. Los Angeles alone will receive $22 million, with the rest of the funds going to cities such as Oakland, San Francisco, Adelanto, Commerce and Desert Hot Springs. Matt Hawkins, managing partner at Entourage Effect Capital and the board chair at Harborside, says the grant will help ease the financial burden on legal companies and allow regulators to process the backlog of licenses much faster.

Newsom has also thrown his weight behind a measure that would extend the Jan. 6, 2022, deadline to apply for provisional licenses by six months. However, it wasn’t included in the most recent state budget bill, and lawmakers are still discussing it.

It is heartwarming to sector players such as XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) to learn that some jurisdictions are taking steps to support the cannabis industry during the pandemic. This is a far cry from the stance of the federal government, which doesn’t recognize state-level cannabis firms as legitimate business concerns.

NOTE TO INVESTORS: The latest news and updates relating to XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) are available in the company’s newsroom at https://cnw.fm/XPHYF

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Monday, June 28th, 2021 Uncategorized Comments Off on $XPHYF 420 with CNW – California Earmarks $100M to Support Licensed Cannabis Firms During Pandemic

$WTER 420 with CNW – Marijuana Could Fuel Novel Food Culture

For decades, plants within the Cannabis Sativa family have been associated with marijuana and its infamous “high.” Even as the state-legal cannabis industry becomes larger and more lucrative, THC (delta-9 tetrahydrocannabinol), the compound responsible for marijuana’s intoxication, has taken center stage. However, cannabis and hemp are extremely versatile and have a wide variety of applications ranging from textiles and construction to health and wellness.

Cannabis is undoubtedly one of the fastest-growing industries in the country, with Ben Larson, CEO of Oakland, California-based firm Vertosa calling it the most exciting growth opportunity since the advent of the internet. Vertosa is a technology company that specializes in deriving ingredients from cannabis for food and beverage manufacturers. During The Future of Food @ SXFW event, which was held virtually from March 18–21, Larson said that cannabis and hemp may be at the heart of a novel food culture in the future.

With his company focusing on beverages infused with cannabis and hemp extracts, Larson pointed out that with all the money being invested into cannabis beverages, the space is looking at a lucrative future. With its versatility, cannabis isn’t just confined to beverages, he says, stating that its applications in health and wellness, athletics and even pet care present an extremely attractive opportunity for growth.

Mario Rodriguez, the owner of New York-based Bootleg Avocado LLC agrees. Rodriguez moderated the SXSW session titled “Cannabis: The Catalyst for New Food Culture,” and he believes that the time has come for the world to dissociate cannabis from the stigma of being an illicit drug and uncover its plethora of food and beverage applications.

In fact, several companies have already jumped onto the bandwagon, producing cannabis beverages that prioritize wellness over intoxication. For instance, Innoviom, which is based in Stamford, Connecticut, has developed a line of beverages called Tranquini Wowie that contains 20 mg of hemp as well as adaptogens such as lavender, chamomile and lemon balm. Designed to offer quick relief from stress and anxiety, a single 12-oz can of the relaxation beverage contains 20 calories. According to CEO Ahmed ElAzizi, Tranquini Wowie can take you from “hectic to hanging loose” without the drowsiness associated with cannabis. In Venice, California, Cann & Bolt Co. has created a nonalcoholic beverage infused with THC and CBD. It leaves users feeling invigorated and gives them a slight buzz thanks to the THC.

Over in Santa Fe, New Mexico, Verde Juice Co. has a line of high-pressure and cold-pressed functional teas and juice beverages that are made using whole hemp leaf juice. Each 10-oz bottle has 12 mg of CBD, less than 1 mg of THC and 35 calories with no added sugar. With companies conducting more research into cannabinoids, terpenes and flavonoids, they are bound to come up with different combinations that will create new dynamic experiences.

Scottsdale, Arizona-based The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) also has a line of CBD-infused products, including drinks, being marketed across the country. This goes to show just how fast the cannabis food culture is growing, with much more to come.

NOTE TO INVESTORS: The latest news and updates relating to The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) are available in the company’s newsroom at http://cnw.fm/WTER

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Monday, June 28th, 2021 Uncategorized Comments Off on $WTER 420 with CNW – Marijuana Could Fuel Novel Food Culture

$TOBAF Announces Sellout of Initial Shipment to Georgia Wholesaler

TAAT(TM) Global Alternatives (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) shipped an initial purchase order to a Peach State Distributor (“PSD”) in Georgia last week; the entire shipment of 15 TAAT(TM) master cases, which was delivered on June 24, 2021, was sold out before the product arrived. The purchase order was part of a company initiative to test the state of Georgia as the next market for a full-scale launch of TAAT, which is an alternative to tobacco cigarettes. The announcement noted the move complements TAAT’s presence in more than 250 retailers in the state of Ohio. The PSD convenience wholesaler has a 1,200-store network, with 90% of its stores located in Georgia; other locations are in North Carolina, South Carolina and Alabama. The announcement noted that the product would be distributed in Georgia and North Carolina, which would become the first official retailers of TAAT on the East Coast. “As we continue to build a brand in the $814 billion global tobacco industry, we have attracted the attention of several distributors across the country through both cold approaches and warm referrals from existing business relationships,” said TAAT CEO Setti Coscarella in the press release. “We chose Georgia as the next market in which we will officially launch TAAT for several strategic reasons, one of which is PSD’s impressive ability to lead commercialization efforts for emerging alternative products similar to TAAT. Further, in addition to the fact that Georgia and Ohio have about the same population size, both states share borders with five other states. Just as launching TAAT in Ohio made the product accessible to smokers aged 21+ in the bordering states of Michigan, Indiana, Kentucky, Pennsylvania and West Virginia, launching TAAT in Georgia provides similar opportunities in Florida, North Carolina, South Carolina, Tennessee and Alabama. TAAT has only been available for purchase at retail for about 200 days now, and retailers in our second expansion market have already bought out 100% of our first shipment to our initial distributor before it even arrived. I believe this is a very positive indicator of our potential as we seek to widen our footprint in the United States this year.”

To view the full press release, visit https://ibn.fm/9x8r9

About TAAT Global Alternatives Inc.

TAAT Global Alternatives has developed TAAT, which is a tobacco-free and nicotine-free alternative to traditional cigarettes offered in Original, Smooth and Menthol varieties. TAAT’s base material is Beyond Tobacco(TM), a proprietary blend that undergoes a patent-pending refinement technique causing its scent and taste to resemble tobacco. Under executive leadership with Big Tobacco pedigree, TAAT was launched first in the United States in Q4 2020 as the company seeks to position itself in the $814 billion global tobacco industry. For more information, please visit www.TAATGlobal.com.

NOTE TO INVESTORS: The latest news and updates relating to TOBAF are available in the company’s newsroom at http://ibn.fm/TOBAF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Monday, June 28th, 2021 Uncategorized Comments Off on $TOBAF Announces Sellout of Initial Shipment to Georgia Wholesaler

$SGTM Positioned to Outperform Previous Record-Breaking Year, Announces 16.7% Q1 QoQ Revenue Growth

June 28, 2021

Sustainable Green Team Ltd. (SGTM) Positioned to Outperform Previous Record-Breaking Year, Announces 16.7% Q1 QoQ Revenue Growth

  • SGTM released Q1-2021 results showing $9,291,931 in revenue, $1,400,720 in gross profit, $41,477,914 in total assets
  • QoQ growth includes 16.7% revenue increase, 8.6% gross profit increase
  • 2020 was record-breaking year: 794% revenue, 4,817% gross profit growth in Q1 and Q2 compared to all of 2019

Sustainable Green Team (OTC: SGTM), a leading provider of environmentally beneficial solutions for tree and storm waste disposal, recently announced Q1-2021 financial results that indicate the company may surpass its record-breaking 2020 financial performance (https://ibn.fm/1Q9cw).

The company posted $9,291,931 in revenue, $1,400,720 in gross profit and $41,477,914 in total assets for the three months ending April 3, 2021. Compared to 2020, the results represent an approximate 16.7% increase in revenue, 8.6% increase in gross profit, and 1.4% increase in total assets compared to the three months ended March 31, 2020.

“Our continued successful recorded financials each quarter and year-end is all thanks to our team,” said SGTM CEO and Director Tony Raynor. “I’m a firm believer that you are only as strong as your team, and our strong growing financials proves such. This year we are anticipating to continue recording strong financials as we start implementing our strategy for 2021.”

SGTM produces environmentally friendly products by diverting natural storm waste from landfills and transforming it into organic garden mulch and playground surfacing material. Through its strategic partners and wholly-owned subsidiaries Mulch Manufacturing Inc. and National Storm Recovery, the company achieves its objectives through tree services, debris hauling and removal, biomass recycling, mulch manufacturing, mulch packaging, next-generation mulch product sales, and the production of specialty cypress lumber.

“Getting paid for your feedstock in the mulch business is a recipe for success and great profit margins,” said Raynor (https://ibn.fm/BlbsX). “Storm recovery is a multibillion-dollar business, and we are prepared to help in any cleanup process.”

While COVID-19 policies sent the global economy into a tailspin, SGTM experienced stellar financial results in 2020 that included a 794% increase in revenue and a 4,817% increase in gross profit during the first half of the year when compared to all of 2019 combined (https://ibn.fm/v0K7Y). Factors contributing to the company’s impressive performance include a record-breaking hurricane season (https://ibn.fm/HqaVK) and increasing lumber prices (https://ibn.fm/Vo8Cw).

The company continues to expand through its strategic partnerships, operational investments, government contracts, and a growing list of commercial clients, including The Kroger Co., Circle K, 7-Eleven, Mendards Inc., Old Castle Lawn & Garden, and more. Based in Jacksonville, Florida, SGTM operates from a 100,000-square-foot warehouse/truck terminal on 26 acres and is managed by a leadership team that leverages over 40 years of next-level experience with mulch manufacturing and tree management.

To learn more about Sustainable Green Team Ltd., view the investor presentation at https://ibn.fm/LtsUa.

NOTE TO INVESTORS: The latest news and updates relating to SGTM are available in the company’s newsroom at http://ibn.fm/SGTM

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.

Monday, June 28th, 2021 Uncategorized Comments Off on $SGTM Positioned to Outperform Previous Record-Breaking Year, Announces 16.7% Q1 QoQ Revenue Growth

$SRAX Updates Sequire Platform with Automated Email, SMS Features

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS (“SaaS”) platform, has announced two additional features: an email feature and SMS feature. According to the announcement, the email feature provides automation to the existing Sequire email system and the SMS feature adds tools that enable sending text messages. The company noted that the additions include automation triggers and other enhancements designed to facilitate seamless communication between companies and their shareholders. SRAX also observed that the new Sequire features are key to maintaining and growing communications with shareholders and contacts, allowing companies to streamline shareholder marketing and communication in the same location where they store data. SRAX added the features through automation enhancements and machine learning; the features also enable users to prepare contact lists, customize messaging to specific audiences, schedule important updates for campaigns and measure audience engagement. “These new tools will allow companies to better manage communication with their shareholder base by defining pre-established triggers that will execute both email and SMS messages,” said SRAX founder and CEO Christopher Miglino in the press release.

To view the full press release, visit https://ibn.fm/bQUtN

About SRAX Inc.

SRAX is a financial technology company that unlocks data and insights for publicly traded companies. Through its premier investor intelligence and communications platform, Sequire, companies can track their investors’ behaviors and trends and use those insights to engage current and potential investors across marketing channels. For more information about the company, please visit www.SRAX.com.

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Monday, June 28th, 2021 Uncategorized Comments Off on $SRAX Updates Sequire Platform with Automated Email, SMS Features

$SBEV Model Leverages Synergistic Acquisitions

Splash Beverage Group (NYSE American: SBEV), a portfolio company of successful beverage brands, has expanded its Tequila footprint in Tampa Bay, a region known for having a high population of millennials. “Tampa is a hotbed for millennials, people aged 24-39 by common definitions, as the median age of a Tampa resident is 34.7 years. The ethos of millennials is rooted in experience and variety, an identity lending to the increased popularity of tequila,” reads a recent article. In January, Splash acquired Copa Di Vino; with this acquisition came a relationship with Pepin Distributing, a 54-year-old wine and spirits distributor that supplies Copa Di Vino in the greater Tampa Bay region. “Under the new ownership of Splash, it didn’t take long for the relationship with Pepin to expand from only Copa Di Vino to now include Splash’s SALT naturally flavored 100% Blanco agave tequila line. The expanded relationship with Pepin is representative of the model of Splash to make synergistic acquisitions on any number of levels, be it manufacturing, marketing or distribution.”

To view the full article, visit https://ibn.fm/Viube

About Splash Beverage Group Inc.

Splash Beverage Group specializes in the manufacturing, distribution, sales, and marketing of various beverages across multiple channels. SBEV operates in both the non-alcoholic and alcoholic beverage segments, which the company believes leverages efficiencies and dilutes risk. SBEV believes its business model is unique as it ONLY develops/accelerates brands it perceives to have highly visible preexisting brand awareness or pure category innovation. For more information about the company, visit www.SplashBeverageGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to SBEV are available in the company’s newsroom at http://ibn.fm/SBEV

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Monday, June 28th, 2021 Uncategorized Comments Off on $SBEV Model Leverages Synergistic Acquisitions

$PLTXF Poised to Bring Plant-Based Diet to the World of Sports Performance; Rémy Métailler Joins Venus Williams as the Brand Ambassador

June 28, 2021

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Poised to Bring Plant-Based Diet to the World of Sports Performance; Rémy Métailler Joins Venus Williams as the Brand Ambassador

  • PlantX expands its list of elite athletes who partner with the company as brand ambassadors to include Rémy Métailler, one of the world’s most renowned professional mountain bike athletes
  • “Rémy’s Picks” has been launched as a personalized web page presenting his curated list of PlantX products
  • Métailler, who also follows a mostly plant-based diet, will promote the company’s product offering in Squamish and the Canadian West Coast and across his personal platforms

PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) continues to be committed to bringing plant-based living to the broadest audience possible, aiming to demonstrate that this lifestyle can be beneficial even for those that put their bodies under the highest levels of physical stress. The Company adds Rémy Métailler, another high-performing athlete, to its line-up of highly accomplished athletes promoting the PlantX product offering (https://ibn.fm/wJRJa). As more and more elite athletes embrace plant-based nutrition, it becomes increasingly recognized that a plant-based diet may offer considerable benefits in the world of professional sports — from potentially enhancing athletic performance and overall health to helping with injury recovery (https://ibn.fm/n1axJ).

Over the recent years, scientists have been studying the role of nutrition in optimizing athletic performance, finding that plant-based diets can help athletes enhance their performance by lowering their weight, creating leaner bodies, and increasing stamina. Today, many elite athletes follow a plant-based diet (https://ibn.fm/h2k4a).

Métailler is one of the world’s most renowned professional mountain bike athletes and a planetary health advocate who has been following a mostly plant-based diet. He will be involved in broadening PlantX’s brand exposure in Squamish and the Canadian West Coast, where he currently resides and where PlantX’s flagship store is located. Originally from France, he moved to Squamish, British Columbia —considered The Adventure Capital of Canada — to live his passion for Mountain Biking and skiing.

He will also leverage his access to audiences across his personal platforms to help in broadening PlantX’s brand exposure. As part of this partnership, PlantX has launched “Rémy’s Picks”, a personalized web page presenting Métailler’s curated list of PlantX products to U.S. and Canadian e-commerce consumers. Metallier will select his favorite plant-based products from brands such as Oatly, Native Forest, Cadia, and Jeff’s Garden (https://ibn.fm/IcGMt).

“I am so excited to partner with PlantX. My diet has been mostly plant-based for several years, and I love trying new recipes,” said PlantX Ambassador, Rémy Métailler. “Having the support of PlantX is a great way to explore new food and lifestyle options and related products that I can share with my community.”

“PlantX’s culture is driven by a passion for sports, plant-based wellbeing, and sustainability, and having Rémy’s support further shows how the Company is attracting exciting new partnerships that reflect our values,” said PlantX Founder, Sean Dollinger. “Rémy is a legend in Squamish and in the world of mountain biking. Collaborating with him will help boost our ties with the Squamish community and our brand exposure among other like-minded athletes and their following base.”

As a company poised to offer a getaway to plant-based living to consumers across North America, PlantX is committed to offering wholesome products across a broad range of categories for anyone interested in living a plant-based lifestyle and thriving in a longer, healthier, and happier life. In doing so, the Company carefully selects partners with values aligned with its own. As an ardent advocate raising awareness of the climate risks and planetary health Métailler appear to be a perfect partner of PlantX in its quest to promote plant-based living and sustainability efforts.

For more information, visit the company’s websites at www.PlantX.comwww.PlantX.ca and https://investor.plantx.com/ and view PlantX for Plant-Based Investors.

To visit the company’s YouTube channel, click here.

NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.

Monday, June 28th, 2021 Uncategorized Comments Off on $PLTXF Poised to Bring Plant-Based Diet to the World of Sports Performance; Rémy Métailler Joins Venus Williams as the Brand Ambassador

$NETE Could Charging EVs Be as Fast as Refilling a Gas Tank?

Electric cars have been dubbed the next frontier of vehicular travel as countries around the world scramble to cut their carbon emissions in a bid to curb climate change. Instead of an internal combustion engine, electric vehicles (“EVs”) use a rechargeable lithium-ion battery coupled with an electric motor for power. Despite their obvious environmental benefits, not everyone is sold on electric vehicles, and slow charging rates are partly to blame.

Unlike filling up a petrol or diesel-powered car, which can be done in as little as five minutes, electric vehicles take quite a while to recharge. Even with fast charging infrastructure, it will take a driver at least 30 minutes to charge an electric vehicle to 80%. For those who own a Tesla, one of the company’s supercharging stations can add up to 200 miles of range in 15 minutes. Although that’s pretty fast, it still pales in comparison to the relative ease and speed of filling a tank with gas and hitting the road without having to worry about where the next charging station is.

Consequently, battery makers have been working on improving charging speeds for electric vehicle batteries while maintaining their integrity and safety. These efforts include the development of new materials for the lithium-ion batteries that EVs currently use, as well as solid state batteries, which use a solid electrolyte rather than a liquid one. Unfortunately, fast charging tends to make batteries overheat and degrade. In worst-case scenarios, high charging speeds can lead to a phenomenon called lithium plating, which can make the battery catch fire or even worse, explode.

As such, all electric vehicle batteries are programmed to take in electricity at lower speeds to keep them from degrading or catching on fire. For fast charging to become the norm, battery makers will have to develop batteries that won’t succumb to lithium plating. Echion Technologies, a UK-based startup, has developed an anode made of niobium that doesn’t allow lithium plating and can be charged super fast. But since these anodes aren’t as energy-dense as graphite cathodes, they currently can’t be used in EVs because this means reduced range on a single charge.

Another power developing alternative battery technology is Solid Power. The company, which has the backing of Ford and BMW Group, is developing solid-state batteries that employ silicon anodes instead of graphite. They can be recharge to 50% capacity in just 15 minutes, and chief technology officer Joshua Buettner-Garrett says Solid Power is hoping to achieve full recharge rates in only 20 minutes. Most of the research on alternative battery components, while quite encouraging, is still in its infancy and will take a couple of years for it to go mainstream.

Even if this technology is perfected, the electricity grid may not be able to support thousands or hundreds of thousands of fast-charging stations. A fast-charging station draws at least 400 volts from the grid, and if everyone were to ditch their fossil fuel cars for EVs, the grid would be put under immense stress. A perfect balance between home charging, office charging and public stations would reduce this strain and keep grid operators from burning dirtier fuels in a bid to support a vast network of fast-charging stations.

As new players such as Net Element (NASDAQ: NETE) join the electric vehicle sector, superior solutions are likely to be found to address many of the issues that have been slowing the uptake of these eco-friendly vehicles.

NOTE TO INVESTORS: The latest news and updates relating to Net Element (NASDAQ: NETE) are available in the company’s newsroom at http://ibn.fm/NETE

About Green Car Stocks

Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge.

To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

Green Car Stocks
San Francisco, California
www.GreenCarStocks.com
415.949.5050 Office
Editor@GreenCarStocks.com

Green Car Stocks is part of the InvestorBrandNetwork.

Monday, June 28th, 2021 Uncategorized Comments Off on $NETE Could Charging EVs Be as Fast as Refilling a Gas Tank?

$IFBD Looks Set to Capture Lion’s Share of China’s SaaS Market

Infobird (NASDAQ: IFBD), a business-to-business (“B2B”) artificial intelligence (“AI”) solutions company, recently pivoted to standardized software-as-a-service (“SaaS”) modules, which are already proving valuable by helping both small-to-medium and mid-to-large enterprises generate more business opportunities. The modules are also fast and easy to roll out, meaning quick scalability is now possible. With the standardization now in place, IFBD appears to have struck a balance and is therefore in a position to emerge as the next industry leader. “Infobird intends to use its already developed standardized SaaS modules and its proprietary no-code development platform to more readily create new SaaS modules with preprogrammed microservices at extremely low cost and therefore quickly adapt to the changing market demands and opportunities,” reads a recent article. “Further, given that IFBD already has proven templates guiding the development of the new standardized modules, its approach and success thus far cannot be easily matched by competitors. These factors mean that Infobird will not only be able to expand its target market and roll out its standardized modules successfully but also looks set to capture the lion’s share of the SaaS market.”

To view the full article, visit https://ibn.fm/Zmu0g

About Infobird Software Co. Ltd.

Infobird, headquartered in Beijing, China, is a software-as-a-service provider of innovative AI-powered or enabled customer engagement solutions. For more information about the company, visit www.Infobird.com.

NOTE TO INVESTORS: The latest news and updates relating to IFBD are available in the company’s newsroom at http://ibn.fm/IFBD

About ChineseWire

ChineseWire (CW) is a specialized communications platform focused on promising China-based companies that are listed in North America. As one of 40+ brands within the InvestorBrandNetwork (“IBN”), CW provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution to IBN’s millions of social media followers; and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, CW is uniquely positioned to best serve private and public Chinese companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CW brings its clients unparalleled visibility, recognition and brand awareness. CW is where news, content and information converge.

For more information, please visit https://www.ChineseWire.com

Please see full terms of use and disclaimers on the ChineseWire website applicable to all content provided by CW, wherever published or re-published: https://www.ChineseWire.com/Disclaimer

ChineseWire
Los Angeles, California
www.ChineseWire.com
310.299.1717 Office
Editor@ChineseWire.com

ChineseWire is part of the InvestorBrandNetwork.

Monday, June 28th, 2021 Uncategorized Comments Off on $IFBD Looks Set to Capture Lion’s Share of China’s SaaS Market

$CBDHF Marks a Significant Milestone in its European Expansion Plan; Announces New Chief Financial Officer

  • HempFusion Wellness Inc. announces it is offering its new EU-compliant products through Boots Ireland
  • This marks the company’s official entry into the Irish market in what is a significant step in further venturing into the U.K. and Europe as a whole
  • Boots will carry HempFusion’s products in close to 50% of stores in the country
  • Following unprecedented circumstances, HempFusion announced a new Chief Financial Officer, Ms. Maria Leal, taking over from Mr. Bruce Valentine
  • Ms. Leal will oversee HempFusion’s finance and accounting functions

HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO) just marked a significant milestone in its European expansion plan. This followed the announcement that it would now be offering its new European Union (“E.U.”) compliant products through its wholly-owned subsidiary, Probulin Probiotics, LLC, via Boots Ireland (https://cnw.fm/An67c).

This entry into the Irish market marks a crucial step in HempFusion Wellness’ ambitious plan to venture into the European market, specifically Ireland, the United Kingdom, and Europe. The move began back in January of 2021 when the initial distribution deal for Ireland was signed, a deal that would see Boots Ireland stock HempFusion’s products in close to 50% of stores in the country.

Boots Ireland is a household name in the Irish market. With a history that dates back to 1849, it has become a well-known brand and an integral part of the community (https://cnw.fm/mGpZ7). The company also serves as part of the Retail Pharmacy International Division of one of the world’s largest purchasers of prescription medication and other health and well-being products. As such, HempFusion’s partnership with Boots Ireland adds substantial value to the brand and plays a critical role in its future expansion plans throughout the rest of Europe and the U.K.

Some of the Probulin products stocked in Irish stores will include Women’s Health Probiotic, Probulin Daily Care probiotic, and Total Care Probiotic. As for HempFusion products, Boots will stock 10 mg      USDA Organic Tincture Oil and 20 mg USDA Organic Tincture Oil (https://cnw.fm/4Em9P).

HempFusion Wellness, based in Denver, is a world-leading health and wellness CBD company. It prides itself in utilizing the power and potential of whole-food hemp oil that’s been extracted using a proprietary method known to preserve greater numbers of cannabinoids (HempOnePassExtraction(TM)). This organically produced oil serves as the foundation of each of its HempFusion products. Similar care and attention make their way to the development and offerings coming from each of its brands, to include HempFusion, Probulin Probiotics, Biome Research, and H.F. Labs (https://cnw.fm/hlkWp).

Currently, the company’s primary market is the United States, where its products are carried in approximately 4,000 retailers in all 50 states. Consequently, its expansion into Ireland marks a considerable milestone in its move to expand globally, and in Europe, specifically.

Additionally, HempFusion announced a new Chief Financial Officer. Ms. Maria Leal, who previously served as the company’s Vice President and Controller, will now take on the position of Interim Chief Financial Officer, taking over from Mr. Bruce Valentine. The latter stepped down effective June 16, 2021, following the unexpected passing of his mother and the duties that arose (https://cnw.fm/0v0X7).

Ms. Leal has had a 20-year-long career, serving in various senior positions in financial accounting. Before joining HempFusion in July 2019, she served as Vice President and Corporate Controller at Galvanize Inc., Vice President, Finance at SharpShooter Imaging, and Vice President, Finance North America, and Treasurer at Magic Memories (https://cnw.fm/AdwbS).

In a statement from Jason Mitchell, the Cofounder, President, and Chief Executive Officer of HempFusion, HempFusion, through its Board, expressed complete confidence in Ms. Leal’s skills and expertise. The Board noted its trust in Ms. Leal succeeding in overseeing HempFusion’s finance and accounting functions. Mr. Mitchell also recognized Ms. Leal’s role within the company and the value that she has added, particularly to developing and implementing financial planning and accounting functions for the duration she has been part of the company.

Ms. Leal holds a CPA and an MBA from Marylhurst University. She also has a Bachelor of Science Degree in Business Administration/Accounting from the California State University- Los Angeles.

For more information, visit the company’s website at www.HempFusion.com/corporate-information.

NOTE TO INVESTORS: The latest news and updates relating to HempFusion are available in the company’s newsroom at https://cnw.fm/CBDHF

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

Monday, June 28th, 2021 Uncategorized Comments Off on $CBDHF Marks a Significant Milestone in its European Expansion Plan; Announces New Chief Financial Officer

$CLXPF Announces Annual Financial Results, Business Highlights and Adelia Milestones

Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, today released financial and business highlights for its financial year ended March 31, 2021. “It has been an incredibly busy and successful year for the Cybin team, expanding both our product development capabilities and our drug development programs,” said Doug Drysdale, CEO of Cybin. “The enormous progress that we have made serves to strengthen the foundation of our organization, upon which we plan to build further in the coming 12 months as we continue our clinical research activities. I want to thank the entire Cybin team, our board of directors and our investors for supporting the important work we are doing to revolutionize the future of mental health care.”

In addition, Cybin announced that its wholly controlled subsidiary, Adelia Therapeutics Inc., has achieved certain earn-out milestones for the period commencing Jan. 1, 2021. The achievements were contemplated by the terms of a contribution agreement dated Dec. 4, 2020, among Cybin, Cybin Corp., Cybin US Holdings Inc. (the “acquiror”), a wholly controlled subsidiary of Cybin, and all of the previous shareholders of Adelia (the “Adelia shareholders”). “These positive catalysts continue to provide the necessary data required to demonstrate that Cybin’s proprietary deuterated psychedelic molecules potentially carry the same pharmacodynamic properties, safety profiles, potency and receptor targeting as their parent molecules,” said Drysdale in the press release. “While the profiles are similar to parent molecules, early research has shown that these proprietary molecules also carry certain characteristics that may lead them to potentially become commercially viable because of their improved stability, bioavailability, controlled psychedelic duration and overall enhanced chemical make-up.”

To view the full press releases, visit https://ibn.fm/hsfB2 and https://ibn.fm/FSU8a

About Cybin Inc.

Cybin is a leading biotechnology company focused on researching and progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches, and treatment regimens for psychiatric disorders. For more information, visit the company’s website at www.Cybin.com.

NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at http://ibn.fm/CYBN

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Monday, June 28th, 2021 Uncategorized Comments Off on $CLXPF Announces Annual Financial Results, Business Highlights and Adelia Milestones

$CNSP WPD Pharmaceuticals to Soon Recruit Patients for Combined Berubicin Clinical Studies

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, sublicenses the compound Berubicin to WPD Pharmaceuticals for 30 countries mainly in Europe and Asia. WPD, a clinical-stage pharmaceutical company, today provided an update on its Berubicin drug candidate clinical development program for the treatment of glioblastoma multiforme (“GBM”). According to the update, WPD plans to commence its Phase Ib/II Study of Berubicin in the treatment of glioblastoma in the second half of 2021. In addition, CNS Pharmaceuticals has announced open enrollment in the United States for its clinical study evaluating the efficacy and safety of Berubicin in the treatment of recurrent GBM. “I am very pleased and excited about the development we have made on Berubicin both in the United States and in Europe. Our combined WPD and CNS clinical studies are going to start to recruit patients shortly, which is an exciting step in the development programs,” said Mariusz Olejniczak, CEO of WPD. “To ensure patients are informed and updated on possible sites, we will use clinicaltrials.gov as the primary source of information. We are hopeful that this is the first step in changing the landscape of glioma treatment with products in our pipeline and trough collaboration with different companies, scientific institutions and our license partners. I would like to take an opportunity to thank both the WPD and CNS teams and our vendors and partners including WWCT and IAG for the hard work during pandemic months.”

To view the full press release, visit https://ibn.fm/tRIpZ

About CNS Pharmaceuticals Inc.

CNS Pharmaceuticals is developing novel treatments for primary and metastatic cancers of the brain and central nervous system. Its lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. CNS holds a worldwide exclusive license to the Berubicin chemical compound and has acquired all data and know-how from Reata Pharmaceuticals Inc. related to a completed Phase 1 clinical trial with Berubicin in malignant brain tumors, which Reata conducted in 2006. In this trial the overall response rate of stable disease or better was 44%. This 44% disease control rate was based on 11 patients (out of 25 evaluable patients) with stable disease, plus responders. One patient experienced a durable complete response and remains cancer-free as of Feb. 20, 2020. These Phase 1 results represent a limited patient sample size and, while promising, are not a guarantee that similar results will be achieved in subsequent trials. During 2021, CNS expects to commence a Phase 2 clinical trial of Berubicin for the treatment of GBM in the U.S., while a sub-licensee partner undertakes a Phase 2 trial in adults and a first-ever Phase 1 trial in pediatric GBM patients in Poland. Its second drug candidate, WP1244, is a novel DNA binding agent that has shown in preclinical studies that it is 500 times more potent than the chemotherapeutic agent daunorubicin in inhibiting tumor cell proliferation. For more information, visit the company’s website at www.CNSPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to CNSP are available in the company’s newsroom at http://ibn.fm/CNSP

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Monday, June 28th, 2021 Uncategorized Comments Off on $CNSP WPD Pharmaceuticals to Soon Recruit Patients for Combined Berubicin Clinical Studies

$AMPG Added to Russell Microcap(R) Index

AmpliTech Group (NASDAQ: AMPG), a designer, developer and manufacturer of state-of-the-art components and semiconductor chips for satellite and 5G communications networks, defense, space, and other commercial applications, today announced that it has joined the Russell Microcap(R) Index. The addition is in conjunction with the index’s annual reconstitution, which took effect after the market’s close on June 25, 2021. “Inclusion in the Russell Microcap Index is a testament to the progress we have made positioning AmpliTech to participate in the build-out of satellite networks, 5G communications and other next-generation networks,” said AMPG CEO Fawad Maqbool. “These systems will provide enhanced data and bandwidth capabilities essential for supporting rapid growth in connected devices, entertainment and gaming content distribution, video conferencing, internet of things (‘IoT’) applications, autonomous-vehicle communications, quantum computing, space exploration and other bandwidth-intensive applications.”

To view the full press release, visit https://ibn.fm/UUR6J

About AmpliTech Group Inc.

AmpliTech Group designs, develops and manufactures state-of-the-art radio frequency (“RF”) components for global satellite communications, telecom (5G & IoT), space, defense, and quantum computing markets as well as provides systems and component design consulting services. AmpliTech has a 13+ year track record of developing high performance, custom solutions to meet the unique needs of some of the largest companies in the global industries it serves. The company is proud of the unique skills, experience and dedication of its focused team, which enables AmpliTech to deliver superior solutions, faster time to market, competitive pricing and excellent customer satisfaction and repeat business. For more information about the company, visit www.AmpliTechinc.com.

NOTE TO INVESTORS: The latest news and updates relating to AMPG are available in the company’s newsroom at http://ibn.fm/AMPG

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Monday, June 28th, 2021 Uncategorized Comments Off on $AMPG Added to Russell Microcap(R) Index

Knightscope Autonomous Security Robot Gets Exposure Boost in Disney+ Episode of ‘Loki’ Series

  • Knightscope develops and manufactures autonomous security robots that utilize an array of technological tools to patrol and monitor client properties on a 24/7 basis
  • The company’s robots have provided more than a million hours of service to clients since 2015, and recently got high-profile attention through an appearance on the Disney+ streaming superhero series “Loki”
  • Knightscope’s ASR robots are dedicated to helping make the United States safer as a whole, providing video and audio data reception, transmission and analysis, to determine if security concerns and the need for crime deterrence or other emergency intervention are present

When Knightscope’s K5 model autonomous security robot (“ASR”) appeared recently in the second episode of the Disney+ superhero streamer “Loki,” it was cast in a futuristic role that had it roaming the aisles of a big box store in the year 2050 (https://ibn.fm/ZtjZQ).

But the AI-equipped Knightscope ASRs are very much a part of our present society, having logged over a million hours of service since 2015 with paying clients, patrolling busy parking lots/structures, shopping malls, hospitals, city parks and corporate campuses across the United States.

Knightscope’s ASRs come in a variety of models. The K5 is designed to function in outdoor environments, performing property security functions in a fully autonomous manner. The K5 may utilize LiDAR, SONAR, GPS and wheel odometer technology to move about its environment recognizing potential obstacles and hazards.

Its surveillance capabilities function through video and audio data that are monitored and recorded in 360 degrees, as well as infrared and thermal scanning in dark conditions, broadcast signal detection, and select image recognition features.

It can communicate with people in its environment through pre-recorded messages, live-streaming text-to-audio technology, and directed audio transmissions. And the Loki episode was perhaps an example of the company’s discretion with clients — the company’s social media posts noted that, after “over a year of keeping our mouths stapled, glued and taped shut,” it could finally talk about its part in the Marvel Cinematic Universe’s multiverse following the airing of the episode (https://ibn.fm/AUd6C).

Property security continues to remain a significant concern for corporate and government clients. As of June 20, Wikipedia listed just shy of 300 mass shooting events in the United States since the beginning of the year that have led to the deaths of nearly 350 people and injuries for more than 1,200 people (https://ibn.fm/tqnrJ).

None of this year’s incidents up to that date have been school related, but the country’s history of occasional gun violence targeting children and school administrators during school hours — particularly since the April 1999 killings at Colorado’s Columbine High School — has driven municipal efforts to provide more technologically enhanced security measures at schools nationwide.

In a recent example, Ohio’s governor announced June 16 that more than $10 million in state-based grants will be awarded to fund security enhancements at K-12 public schools and institutions of higher education in the state this year and early next year (https://ibn.fm/UxuhP).

“It’s important that we work proactively to ensure that our school buildings and grounds are as safe as possible to protect both students and staff,” Governor Mike DeWine stated. “Two new grant programs offered through the Ohio School Safety Center will help schools and universities pinpoint any weaknesses in their physical security and make needed improvements and upgrades.”

In May, a Utah teacher was hailed as a hero for preventing a man from kidnapping an 11-year-old girl or harming other students on an elementary school playground after the teacher saw the stranger behave aggressively and rushed out to respond to the situation (https://ibn.fm/iPDsp).

Knightscope has declared its mission to make the nation safer through vigilance and a non-threatening IP.

“A violent crime occurs every four seconds and a property crime every 25 seconds. … Crime has more than a trillion-dollar negative economic impact on the U.S. every single year,” Knightscope founder and CEO William Santana Li said in a YouTube video about the company earlier this year (https://ibn.fm/MRztb). “The ongoing mass shooting violence across the country is not acceptable. That is why I put in 80-100-hour weeks to do something meaningful about it.”

For more information, visit the company’s website at www.Knightscope.com and if you have a need for subscription service you may request a private demonstration of the technology at www.Knightscope.com/Demo.

NOTE TO INVESTORS: The latest news and updates relating to Knightscope are available in the company’s newsroom at https://ibn.fm/Knight

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Monday, June 28th, 2021 Uncategorized Comments Off on Knightscope Autonomous Security Robot Gets Exposure Boost in Disney+ Episode of ‘Loki’ Series

$WTER Announces Plans to Join Russell Microcap Index

  • WTER to join Russell Microcap Index effective June 28, 2021
  • Addition to prestigious microcap Index will only heighten awareness of WTER stock on Wall Street
  • Membership in Russell Microcap Index includes automatic listing in other appropriate growth and value style indexes

The country’s largest independent alkaline water company, The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), will join the Russell Microcap(R) Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the U.S. market opens on June 28, 2021 (https://cnw.fm/hZI82). The Russell indices are heavily used and relied on by investment managers as well as institutional investors.

“We are honored to be included in the Russell Microcap Index,” said WTER president and CEO Richard A. Wright. “Joining the Nasdaq exchange two and a half years ago brought our company visibility in the investment community. Our addition to the Russell Microcap Index will only heighten the awareness of our stock on Wall Street.”

Russell indexes are part of FTSE Russell, a leading index provider known for providing critical innovative benchmarking, analytics and data solutions for investors around the world. FTSE Russell calculates thousands of indexes that measure and benchmark markets and asset classes in more than 70 countries; its indexes cover 98% of the global investable market. WTER noted that an estimated $10.6 trillion in assets are benchmarked against Russell’s US indexes.

Along with membership in the Russell Microcap Index comes automatic inclusion in other appropriate growth and value style indexes. Membership in those indexes is determined by FTSE Russell based on objective, market-capitalization rankings and style attributes.

The Alkaline Water Company’s inclusion in these indexes is clear evidence of its success in building a strong, successful beverage portfolio that includes Alkaline88(R), known for its superior hydration with a perfect 8.8pH balance; A88 Infused(R), which includes flavored waters and CBD waters; and A88CBD(TM), a line of CBD ingestibles and topicals. The company is dedicated to purity, quality, value and taste, and is focused on making a difference in the water people drink.

“According to Nielsen for the 52 weeks ending 4/24/21, we continued to outperform the category over 2x in sales volume and over 13x in unit volume,” said Wright. “We are now the largest independent alkaline water company in the country, and we are seeing accelerated growth in our single-serve, aluminum and flavored waters. Our clients, consumers and shareholders are all important to us, and we’re working hard to add value for each of them.”

For more information, visit the company’s website at www.TheAlkalineWaterCo.com and www.a88CBD.com.

NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://cnw.fm/WTER

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

Thursday, June 24th, 2021 Uncategorized Comments Off on $WTER Announces Plans to Join Russell Microcap Index

$SRAX Announces Availability of LD Micro Invitational Replays

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS (“SaaS”) platform, hosted the 2021 LD Micro Invitational earlier this month. The elite three-day virtual investor conference featured more than 200 microcap companies, including the top financially performing companies from the LD Hall of Fame. In addition, several industry experts presented keynote addresses, including Jaime Rogozinski, Rishi Khanna, Matt Hulsizer, Laurie Segall and Liz Claman. SRAX announced that replays from the conference presentation are available to view for three months. SRAX runs several industry-focused investor conferences a year, as well as providing a suite of solutions to help public companies engage with new and existing shareholders. Founded in 2006 as a newsletter, LD Micro is an invaluable independent resource in the micro-cap space. The company now hosts virtual and in-person events and is a leader in small- and micro-cap conferences. With its recent SRAX acquisition, LD gained access to the largest active base of micro-cap investors in the world, numbering more than 2 million.

To view event presentations, visit https://ibn.fm/qZejm

To view the full press release, visit https://ibn.fm/o2rxH

About SRAX Inc.

SRAX is a financial technology company that unlocks data and insights for publicly traded companies. Through its premier investor intelligence and communications platform, Sequire, companies can track their investors’ behaviors and trends and use those insights to engage current and potential investors across marketing channels. For more information about the company, please visit www.SRAX.com.

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Thursday, June 24th, 2021 Uncategorized Comments Off on $SRAX Announces Availability of LD Micro Invitational Replays

$SBEV Engages Great Bay to Extend Reach of SALT Tequila Brand

Splash Beverage Group (OTCQB: SBEV), a portfolio company of leading beverage brands, today announced that its SALT tequila is now distributed by Great Bay Distributors Inc., Florida’s largest independent Anheuser Busch products distributor. According to the update, the agreement complements the representation of Copa Di Vino, a premium single-serve wine that gained national attention on the investment television show Shark Tank. “We’re thrilled to engage Great Bay Distributors to champion SALT tequila into the St. Petersburg and neighboring markets,” said Robert Nistico, CEO of Splash. “With over 350 experienced and dedicated Great Bay team members, SALT Tequila is in the hands of distribution experts, and we expect that the brand will enjoy swift market adoption under their leadership. The team at Great Bay is second to none, and beyond regular distribution, the team markets, promotes and sponsors many local events. Moreover, this new agreement does more than validate the premium quality of SALT Tequila; it also shows the respect it is earning from top-tier distribution companies.”

To view the full press release, visit https://ibn.fm/BxPkn

About Splash Beverage Group Inc.

Splash Beverage Group specializes in manufacturing, distribution, sales and marketing of various beverages across multiple channels. SBEV operates in both the non-alcoholic and alcoholic beverage segments, which the company believes leverages efficiencies and dilutes risk. SBEV believes its business model is unique as it only develops/accelerates brands it perceives to have highly visible preexisting brand awareness or pure category innovation. For more information about the company, visit www.SplashBeverageGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to SBEV are available in the company’s newsroom at http://ibn.fm/SBEV

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Thursday, June 24th, 2021 Uncategorized Comments Off on $SBEV Engages Great Bay to Extend Reach of SALT Tequila Brand

$RWBYF Featured in Editorial as ‘Super State’ Operator

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, is spotlighted in an editorial broadcast titled “A Lesson in Cannabis: Second Mover Can Be Better Position.” A press release announcing the broadcast observes that, while many look at first-mover status as an optimal position, there can be some advantages to learning from those acting first in an industry. “Look what happened to MySpace and AIM (AOL Instant Messenger) as they faded to irrelevance as Snapchat, TikTok and Instagram exploded in popularity to challenge incumbent platforms,” the press release states. “Second movers can enjoy advantages as they learn from pioneering entities that paved the way. Specific to the cannabis business, there is no shortage of companies that learned from sad experience the price to pay for expanding too fast, overpaying for acquisitions, or building a business a mile wide and a foot deep. Red White & Bloom Brands Inc. is a compelling mix of old and new that is methodically building a commanding position in the United States as a multi-state operator (‘MSO’). In fact, the company refers to itself as a ‘super state operator,’ a reflection of its strategy to remain hyperfocused on dominating specific markets before expanding to others, which ensures it doesn’t get spread too thin.”

To view the full press release, visit https://ibn.fm/4W82f

About Red White & Bloom Brands Inc.

Red White & Bloom Brands is positioning itself to be one of the top-three, multistate cannabis operators active in the U.S. legal cannabis and hemp sector. RWB is predominantly focusing its investments on major U.S. markets, including Michigan, Illinois, Massachusetts, Arizona and California, with respect to cannabis, as well as the United States and internationally for hemp-based CBD products. For more information about the company, please visit www.RedWhiteBloom.com.

NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at http://ibn.fm/RWBYF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Thursday, June 24th, 2021 Uncategorized Comments Off on $RWBYF Featured in Editorial as ‘Super State’ Operator

$POAI Companies Participate in Popular Biotechnology Innovation Organization Digital Conference

  • More than 3,200 pharmaceutical and biotech companies, plus government and academic organizations attended latest BIO Conference
  • Predictive Oncology’s Helomics, TumorGenesis, Soluble Biotech all attended the virtual conference from June 14-18, 2021
  • Companies leveraged different components of the conference to entertain new partnerships or customers

Every industry has a revolving calendar of events, but some are “must attends” due to their global reach and prospective deal flow, like conferences put on by Biotechnology Innovation Organization, or just “BIO” as it’s known. This year, three wholly owned subsidiaries of Predictive Oncology (NASDAQ: POAI) – Helomics, TumorGenesis and Soluble Biotech – attended BIO DIGITAL, a premier international biotech partnering event held virtually on June 10-11 & 14-18, 2021. The Predictive Oncology companies attended the event during the second leg of the conference.

BIO is the world’s largest advocacy association representing member companies, state biotechnology groups, academic and research institutions, and related organizations across the U.S. and in 30+ countries. This year’s virtual conference attracted more than 3,200 pharmaceutical and biotech companies, in addition to government and academic organizations.

Each year, the BIO events feature presentations from key opinion leaders and some of the world’s brightest scientific minds discussing the latest breakthroughs in medicine. While informative, the thrust of attending for companies like that of Predictive Oncology is networking and one-on-one sessions that can result in new partnerships or customers.

“In previous conferences Soluble Biotech has typically received more than a dozen requests for proposals, leading to new contracts for their main service of providing protein therapeutic formulations (i.e., formulations for vaccines, antibodies, virus-like particles),” said Predictive Oncology CEO J. Melville Engle. He added that the Helomics unit is leveraging BIO’s one-on-one sessions to showcase its precision medicine discovery platform branded “PeDAL” (https://ibn.fm/To6tz).

PeDAL, an acronym for Patient-centric Drug Discovery using Active Learning, is a unique technology that combines a proprietary, clinically-validated tumor profiling assay, a knowledgebase of proprietary and public data together with active learning. The active learning allows for the efficient exploration of drug responses against a large diverse patient biology “space.”

The conference allowed TumorGenesis to market its products and services specialized on culturing cancer cells from ovarian and breast cancers that more accurately mimic a patient’s tumors. TumorGenesis technology effectively “fools” ovarian cancer cells into growing outside the body, where they can be studied to better understand the efficacy and safety of cancer drugs specific to the patient. These improved ex-vivo tumor models can then be used by researchers to investigate cancer and by clinicians to develop patient-specific treatment plans.

Engle summed up the comprehensiveness of POAI’s divisions in saying, “Our unique approach allows Pharma therapeutic groups to see how we embrace the complexity and diversity of patient tumors in a highly-scalable and efficient experimental exploration of drugs and drug combinations for patient-specific populations.” And, thanks to organizations like BIO, all the companies’ utility and value can be showcased at global scale.

For more information, visit the company’s website at www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Thursday, June 24th, 2021 Uncategorized Comments Off on $POAI Companies Participate in Popular Biotechnology Innovation Organization Digital Conference